Arformoterol
Back to searchMolecule Structure
Scientific Name
Arformoterol
Description of the Drug
Arformoterol is a beta-2 adrenergic agonist and bronchodilator used for long-term, symptomatic treatment of reversible bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01274
http://www.drugbank.ca/drugs/DB01274
Brand Name(s)
Not Available
Company Owner(s)
Cipla Ltd, Alembic Pharmaceuticals Ltd, Lupin Inc, Sun Pharmaceutical Industries Ltd, Tap Pharmaceuticals Ag, Glenmark Pharmaceuticals Ltd, Vistapharm Inc, Teva Pharmaceuticals Usa, Sunovion Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4247 | ||
| PharmGKB | PA164743977 | ||
| Human Metabolome Database | HMDB0015399 | ||
| DrugBank | DB01274 | ||
| PubChem: Thomson Pharma | 14827391 | 14900508 | |
| PubChem | 3083544 | ||
| Nikkaji | J245.605B | ||
| PDBe | H98 | ||
| BindingDB | 50151720 | ||
| EPA CompTox Dashboard | DTXSID40110071 | DTXSID1023077 | |
| DrugCentral | 4943 | ||
| Brenda | 217390 | ||
| ChemicalBook | CB7722411 | ||
| Guide to Pharmacology | 7479 | ||
| rxnorm | BROVANA | ARFORMOTEROL | ARFORMOTEROL TARTRATE |
| ChEBI | 408174 | ||
| ZINC | ZINC000002599970 |
